Using liquid biopsies to test for ESR1 mutations in breast cancer is more feasible for patients and has quicker turnaround ...

Importance of Bio-Techne’s New Assay While ESR1 gene mutations are extremely rare in cancer patients before treatment, the use of endocrine therapies causes these mutations to emerge in as many ...

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment ...

Seth Wander, MD, PhD, discusses the extended survival with elacestrant in a real-world, which was longer than the randomized phase 3 trial data.

Around 70% of all metastatic breast cancer cases are HR-positive and HER2-negative, and ESR1 mutations are found in up to 40% of these tumours. That suggests there should be plenty of eligible ...

Vepdegestrant met the primary endpoint in ESR1-mutant breast cancer, significantly improving progression-free survival over fulvestrant. The trial did not achieve statistical significance for PFS ...

VERITAC-2 trial shows vepdegestrant improves progression-free survival in ESR1-mutant breast cancer, marking a clinical milestone for PROTAC therapy. The trial did not reach statistical ...

Piper Sandler lowered the firm’s price target on Arvinas (ARVN) to $24 from $67 on narrowed vepdegestrant ESR1-mutant mBC approval, while ...

P1220-ESR1 supports High-Profile H.264 compression, a vast improvement in quality over MPEG-4 and 20 times more efficient than MJPEG. Pelco SD435-PG-E1-X true day / night external PTZ dome camera - ...